| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 14.65B | 14.43B | 14.26B | 14.21B | 13.69B | 14.30B |
| Gross Profit | 4.45B | 4.37B | 4.26B | 4.19B | 3.92B | 4.19B |
| EBITDA | 2.44B | 2.31B | 2.23B | 2.44B | 2.26B | 2.31B |
| Net Income | 1.48B | 1.38B | 1.65B | 1.41B | 1.25B | 1.25B |
Balance Sheet | ||||||
| Total Assets | 10.54B | 10.65B | 11.32B | 10.12B | 9.82B | 12.28B |
| Cash, Cash Equivalents and Short-Term Investments | 834.00M | 1.10B | 2.30B | 1.27B | 1.19B | 1.56B |
| Total Debt | 8.22B | 8.75B | 8.74B | 7.31B | 7.21B | 7.79B |
| Total Liabilities | 15.98B | 15.92B | 16.04B | 14.84B | 14.48B | 15.26B |
| Stockholders Equity | -5.68B | -5.39B | -4.85B | -4.92B | -4.87B | -3.63B |
Cash Flow | ||||||
| Free Cash Flow | 1.67B | 1.44B | 1.44B | 1.49B | 1.45B | 1.59B |
| Operating Cash Flow | 1.82B | 1.60B | 1.56B | 1.63B | 1.56B | 1.75B |
| Investing Cash Flow | -230.00M | -406.00M | -239.00M | -183.00M | -33.00M | -89.00M |
| Financing Cash Flow | -2.69B | -2.42B | -234.00M | -1.35B | -3.65B | 58.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | $109.31B | 31.24 | 24.69% | 0.79% | 6.03% | 4.26% | |
77 Outperform | $50.33B | 28.74 | 30.25% | 1.33% | 10.45% | 21.30% | |
71 Outperform | $76.41B | 29.72 | 12.11% | 1.58% | 4.03% | 3.51% | |
70 Outperform | $72.56B | 24.43 | 97.38% | 2.43% | 2.90% | -5.25% | |
67 Neutral | $27.75B | 40.88 | 5.80% | 0.10% | 6.86% | -26.67% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
58 Neutral | $27.92B | 22.00 | -27.10% | 1.88% | 3.34% | -1.24% |